BlackRock Investment Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

BlackRock Investment Management’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-170,684	Closed	-$249K	–	4283
2016 Q1	$249K	Buy	170,684 +4,720	+3%	+$9.31K	﹤0.01%	3120
2015 Q4	$531K	Buy	165,964 +1,778	+1%	+$8.55K	﹤0.01%	2985
2015 Q3	$1.03M	Sell	164,186 -4,760	-3%	-$44.5K	﹤0.01%	2578
2015 Q2	$1.68M	Buy	168,946 +42,855	+34%	+$375K	﹤0.01%	2374
2015 Q1	$929K	Buy	126,091 +15,676	+14%	+$105K	﹤0.01%	2571
2014 Q4	$591K	Buy	110,415 +5,707	+5%	+$29.2K	﹤0.01%	2918
2014 Q3	$527K	Buy	104,708 +1,547	+1%	+$9.51K	﹤0.01%	2941
2014 Q2	$692K	Buy	+103,161	New	+$657K	﹤0.01%	2854

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Investment Management's NWBO Position: Q2 2016 in Review

BlackRock Investment Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 170,684 shares — an estimated $249K sold.

BlackRock Investment Management first reported a position in NWBO in Q2 2014 and held it in 8 quarters. The position peaked at $1.68M in Q2 2015. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

BlackRock Investment Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 170,684 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $249K.
BlackRock Investment Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 8 quarters.
BlackRock Investment Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $1.68M in Q2 2015.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.